Wikidata

(Q64659815)

English

A Study of a Combination of Trastuzumab and Capecitabine With or Without Pertuzumab in Patients With HER2-positive Metastatic Breast Cancer (PHEREXA)

clinical trial

In more languages

Statements

title
A Multicenter Randomized Phase III Study to Compare the Combination Trastuzumab and Capecitabine, With or Without Pertuzumab, in Patients With HER2-Positive Metastatic Breast Cancer That Have Progressed After One Line of Trastuzumab-Based Therapy in the Metastatic Setting (PHEREXA) (English)
0 references
sponsor
Hoffmann-La Roche
0 references
country
Argentina
0 references
Austria
0 references
Belgium
0 references
Brazil
0 references
Canada
0 references
Croatia
0 references
Estonia
0 references
France
0 references
Germany
0 references
Hungary
0 references
Italy
0 references
Mexico
0 references
Netherlands
0 references
Peru
0 references
Poland
0 references
Romania
0 references
Spain
0 references
Thailand
0 references
United Kingdom
0 references
start time
26 January 2010
0 references
end time
29 May 2015
0 references
number of participants
452
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64659815&oldid=1857898418"